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http://dx.doi.org/10.1016/j.devcel.2016.01.006The activity of themTORC1protein complex depends onmultiplemetabolic inputs that regulate dimerization,
recruitment to the lysosome, and activation. In this issue of Developmental Cell, David-Morrison et al. (2016)
show that the Drosophila protein Wacky and its mammalian counterpart WAC act as adaptors in the process
of mTORC1 dimerization.The mechanistic target of rapamycin
(mTOR) is a conserved protein kinase
present in two distinct complexes,
mTORC1 and mTORC2, that play a
central role in integrating extracellular sig-
nals to modulate intracellular functions.
Active mTORC1 increases translational
capacity while repressing macro-auto-
phagy (hereafter called autophagy), a
cellular degradation process that contrib-
utes tomaintaining homeostasis and con-
trollingmacromolecule quality (Feng et al.,
2014).mTORC1 also promotes glycolysis,
the pentose phosphate pathway, de novo
lipogenesis, and nucleotide synthesis—
anabolic pathways that provide building
blocks to sustain cellular growth.
Given mTOR’s role in cellular homeo-
stasis and its implication in human dis-
ease, a plethora of studies have been
undertaken to decipher its regulation
(Laplante and Sabatini, 2012). These
studies have shown that mTORC1 activa-
tion (Dibble and Manning, 2013) directly
depends on the GTPase Rheb (Ras-ho-
molog enriched in brain), whose activity
is repressed by the tumor suppressor
complex (TSC) (Figure 1). TSC is regu-
lated by REDD1 (regulated in develop-
ment and DNA damage responses 1)
and AMPK (AMP-activated protein ki-
nase), which respond to oxygen and
ATP levels, respectively. In the presence
of amino acids, a dimer of Rag GTPases
(RagA/B bound to RagC/D) recruits
mTORC1 to the lysosomal membrane in
close proximity to Rheb. This recruitment
involves a membrane-associated vacu-
olar H+-ATPase (v-ATPase) and the Ragu-
lator, whose conformational change con-
verts the RagA/B-RagC/D dimer into its
active form. More recently, mTORC1 has
also been shown to respond to tricarbox-
ylic acid (TCA) cycle activity (Kim et al.,
2013). Energetic stress associated withlower TCA cycle production of ATP pro-
vokes dissociation of the Tel2-Tti1-Tti2
(TTT)-RUVBL1/2 complex that in turn im-
pinges on mTORC1 homodimer forma-
tion, a process that is necessary for effi-
cient signaling (Yip et al., 2010). Thus,
multiple metabolic inputs act on succes-
sive steps in the mTORC1 pathway.
The discovery of the mTOR counterpart
in Drosophila (dTOR) (Oldham et al., 2000;
Zhang et al., 2000) has enabled use of
powerful genetic tools todeciphermTORC
regulation. In this issue of Developmental
Cell, using an unbiased screening strategy
to identify factors involved in neuro-
degeneration in Drosophila, David-Morri-
son et al. (2016) found that Wacky, and
ultimately its mammalian counterpart
WAC, are required formetabolism-depen-
dent mTORC1 dimerization. The authors
found that in flies, loss of wacky function
in the retina led to photoreceptor degener-
ation and increased autophagy. This
observation contrasts with a previous
study, which identified WAC as a gene
product absolutely required for starva-
tion-induced autophagy in mammalian
cells (McKnight et al., 2012). To further
investigate the role of Wacky in regulating
autophagy, the authors analyzed mutant
cells in the fat body, an insect organ with
hepatic and adipose functions that re-
sponds strongly to nutritional status.
They observed that, at the mid-third larval
stage when larvae are normally actively
feeding, wacky mutant cells did not
undergo starvation-induced autophagy
following nutrient deprivation—consistent
with the requirement of WAC in starva-
tion-induced autophagy in mammals. In
contrast, when analyzed at earlier or later
developmental stages,wackymutant cells
exhibited an increase in basal autophagy.
Consistently, the authors also observed
an increase in basal autophagic markersDevelopmental Cell 3in WAC-knockdown mammalian cells.
In summary, in both Drosophila and
mammalian cells, the lack of Wacky/
WAC increases basal autophagy but also
impedes starvation-induced autophagy.
Proteomic analysis for Wacky partners
led to the identification of dTOR, the
RUVBL1/2 Drosophila counterparts (Pon-
tin/Reptin), and Vha100-2, a component
of the v-ATPase. Consistent with these
findings, phenotypic analysis of wacky
mutant was strongly reminiscent of the
dTOR loss-of-function phenotype, sug-
gesting that Wacky may regulate dTOR
function. To study the mechanism by
which Wacky/WAC may affect mTOR ac-
tivity, the authors turned to mammalian
cells. Co-immunoprecipitations using
cell extracts revealed that WAC knock-
down affected neither the assembly of
the TTT and RUVBL1/2 complexes nor
their interaction with mTORC1. It did,
however, significantly reduce the associ-
ation of these complexes with each other.
Further investigation led to a model in
which WAC acts as an adaptor linking
the mTORC1-loaded TTT and RUVBL1/2
complexes, thereby facilitating mTORC1
dimerization (Figure 1). These results
thus fill a gap in our understanding of the
multiple steps in the mTORC1 regulatory
pathway.
The authors also found that glucose/
glutamine depletion, which induces a se-
vere reduction in TCA cycle activity, re-
sults in reduced interaction between
mTORC1 and components of the TTT or
RUVBL1/2 complexes, suggesting that
the energetic effect operates on mTORC1
loading onto these complexes before their
WAC-induced association with each
other. However, further experiments may
be required to ascertain the timing of the
interactions, since a previous study sug-
gested that the TTT/mTORC1 interaction6, January 25, 2016 ª2016 Elsevier Inc. 129
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Figure 1. Several Metabolic Inputs Control the Multi-step Process of mTORC1 Activation
mTORC1 dimerization is controlled by TCA cycle activity; dimerization begins with the loading of mTORC1
onto the TTT and RUVBL1/2 complexes, followed by WAC-dependent association of the two mTORC1-
containing complexes (shown by David-Morrison et al., 2016). Other metabolic inputs also affect mTORC1
activation at later steps. An increase in amino acid levels in the lysosome induces the recruitment of
mTORC1, which can be activated by Rheb. TSC-mediated repression of Rheb is controlled by AMPK and
REDD1, which respond to AMP/ATP levels and hypoxia. Growth factor regulation, which targets com-
ponents of the TSC and mTORC1 complexes, is not shown in the figure.
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TTT- RUVBL1/2 complex association oc-
curs before mTORC1 loading (Kim et al.,
2013).
In cancer cells, a dramatic increase in
mTORC1 activity is likely due to growth
factors that impinge on TSC-mediated
repression (Dibble and Manning, 2013).
It is intriguing that metabolic inputs oper-
ate on several distinct steps in the
mTORC1 regulatory pathway (Figure 1),
whereas growth factors appear to act
solely on the TSC/Rheb/mTORC1 mod-
ule. It is possible that these metabolically
regulated steps constitute energetic
checkpoints that act prior to mTORC1
growth factor stimulation. Alternatively,
normal mTORC1 activity might depend
predominantly on metabolic inputs,
consistent with the fact that mTORC1130 Developmental Cell 36, January 25, 201also operates in non-growing cells. This
latter possibility is consistent with the
fact that lowering mTORC1 activity in the
adult eye leads to degeneration of photo-
receptors, typically non-growing cells that
are probably not exposed to growth factor
stimulation (David-Morrison et al., 2016).
It therefore appears plausible that growth
factor stimulation regulates mTORC1
signaling solely under extreme growing
conditions, for instance during specific
developmental phases, in tumors or in
culture cells raised in media containing
very high levels of growth factors and nu-
trients, whereas in most other cells,
mTORC1 activity is calibrated by meta-
bolic inputs to maintain homeostasis.
In contrast to previous Drosophila
screens based on growth-related pheno-
types, David-Morrison et al. (2016)6 ª2016 Elsevier Inc.discovered an mTORC1 regulator in a
screen for photoreceptor neurodegenera-
tion. Interestingly, WAC loss-of-function
mutations cause a clinical syndrome
associated with intellectual disability (De-
Santo et al., 2015). Since neurological dis-
orders are often associated with accumu-
lation of toxic aggregates due to
misfolded proteins, promoting autophagy
may be an appealing strategy for clearing
these aggregates (Laplante and Sabatini,
2012). However, considering that WAC
knockdown increases basal autophagy,
the role of mTORC1 in the WAC-related
syndrome will first need to be precisely
evaluated.REFERENCES
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